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Sodium variability is associated with
increased mortality in severe burn injury
Soman Sen*, Nam Tran, Brian Chan, Tina L. Palmieri, David G. Greenhalgh and Kiho Cho
Abstract
Background: Dysnatremias are associated with increased mortality in critically ill patients. Hypernatremia in burn
patients is also associated with poor survival. Based on these findings, we hypothesized that high plasma sodium
variability is a marker for increased mortality in severely burn-injured patients.
Methods: We performed a retrospective review of adult burn patients with a burn injury of 15% total body surface
area (TBSA) or greater from 2010 to 2014. All patients included in the study had at least three serum sodium levels
checked during admission. We used multivariate logistic regression analysis to determine if hypernatremia,
hyponatremia, or sodium variability independently increased the odds ratio (OR) for death.
Results: Two hundred twelve patients met entry criteria. Mean age and %TBSA for the study was 45 ± 18 years and
32 ± 19%. Twenty-nine patients died for a mortality rate of 14%. Serum sodium was measured 10,310 times overall.
The median number of serum sodium measurements per patient was 22. Non-survivors were older (59 ± 19 vs.
42 ± 16 years) and suffered from a more severe burn injury (50 ± 25% vs. 29 ± 16%TBSA). While mean sodium
was significantly higher for non-survivors (138 ± 3 milliequivalents/liter (meq/l)) than for survivors (135 ± 2 meq/l),
mean sodium levels remained within the laboratory reference range (135 to 145 meq/l) for both groups. Non-survivors
had a significantly higher median number of hypernatremic (> 145 meq/l) measurements (2 vs. 0). Coefficient of
variation (CV) was significantly higher in non-survivors (2.85 ± 1.1) than survivors (2.0 ± 0.7). Adjusting for TBSA, age,
ventilator days, and intensive care unit (ICU) stay, a higher CV of sodium measurements was associated with mortality
(OR 5.8 (95% confidence interval (CI) 1.5 to 22)). Additionally, large variation in sodium ranges in the first 10 days of
admission may be associated with increased mortality (OR 1.35 (95% CI 1.06 to1.7)).
Conclusions: Increased variability in plasma sodium may be associated with death in severely burned patients.
Keywords: Sodium, Burns, Critical illness, Ions, Hypernatremia, Hyponatremia
Background
Sodium metabolism is usually tightly regulated at the cel-
lular and organ level. Alterations in plasma sodium may
be a consequence of iatrogenic interventions such as
intravenous fluid administration and medication or may
portend altered physiology and may be a marker for a
rapid decline in health. For critically ill patients, dysnatre-
mias are among the most common electrolyte abnormal-
ities. Dysnatremias are also associated with increased
mortality in critically ill patients [1]. Sodium is an extra-
cellular cation, and it is the primary and most osmotically
active cation in the body [2]. As a result, both cellular and
plasma concentrations are tightly regulated. This regula-
tion is mediated through the kidney via several neurohor-
monal mechanisms. Disruption of this regulation results
in abnormal sodium levels that reflect abnormalities in
serum water content and circulating plasma volume [3].
These changes can have profound effects on a patient’s
physiology resulting in increased morbidity and mortality.
For critically ill patients, the abnormal sodium concen-
trations arise from several sources. First, administration
of sodium containing fluids contributes to the develop-
ment of dysnatremias. Most of these fluids are given
intravenously and account for the majority of daily so-
dium load [4]. Additionally, while sodium administration
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for critically ill patients are generally above the daily rec-
ommended level, the osmotic concentration of the sodium
containing fluids also contribute to altered plasma sodium
concentration [5]. The use of hypotonic fluids can increase
total body water causing the development of hyponatremia.
In contrast, hypertonic fluids can result in a relative loss of
total body water resulting in hypernatremia [6]. Second, a
number of medications can contribute to the development
of dysnatremias. A number of commonly used medications
such as thiazide diuretics, proton-pump inhibitors, and an-
tipsychotics impair renal salt metabolizing function and
cause salt wasting producing hyponatremia. Other medica-
tions such as loop diuretics, antifungals, and osmotic cath-
artic agents (lactulose) can cause loss of water and volume
depletion resulting in hypernatremia [7]. Third, alterations
in renal function contribute to the development of dysna-
tremias. These alterations may be in response to the chan-
ging physiology as a result of injury, inflammation, or
infection resulting in an increased absorption of water by
the kidneys [8]. The alterations may also reflect disrupted
neurohormal regulation resulting in the inability of the
nephrons to absorb water and concentrate the urine [9].
Declining renal function as a result of either pre-existing
renal impairment or acute renal injury can also result in al-
tered renal sodium and water filtration [10, 11]. Fourth,
medical conditions such as diabetes, congestive heart fail-
ure, cirrhosis, hypothyroidism, and hypopituitarism can all
underlie altered plasma sodium concentration. Add-
itionally, severe cutaneous injuries such as burn injur-
ies and blast injuries result in the loss of both water
and sodium [12].
For burn patients, hypernatremia that occurs within
a few days of injury may be associated with increased
risk of death [13]. Additionally, early hypernatremia
may effect wound healing and skin grafting success
[14]. Most of the studies investigating the impact of
dysnatremias on survival in critically ill patients focus
on admission or early development of either hyper or
hyponatremia [5, 15]. However, more recent evidence
suggest that more subtle variations of plasma sodium
concentration may have an impact of outcomes for
critically ill patients [16]. Moreover, sodium variability
during a patient’s hospital course may be a marker of
physiologic decline [17, 18]. Incorporating alterations
in sodium levels with other clinical indicators of
physiologic status may improve the accuracy and pre-
cision of determining a severely burned patient’s clin-
ical course. Based on these recent findings, we
hypothesized that sodium variability will be independ-
ently associated with an increased risk of death in se-
verely burned patients. Our aim for this study was to
determine if sodium variability, hypernatremia, and
hyponatremia are associated with increased mortality
in severely burned adult patients.
Methods
We performed a retrospective cohort study involving
adult (18 years and older) patients who suffered a
15% total body surface area (TBSA) burn injury from
2010 to 2014. We obtained permission to perform the
study from the University of California Davis Institu-
tional Review Board. All data were obtained from the
patient’s electronic health record. Data collected in-
cluded the following: age, gender, TBSA of burn injury,
discharge disposition, mortality, intensive care unit
(ICU) length of stay, and ventilator days. We also col-
lected all plasma sodium measurements available during
the entire hospitalization period for all patients included
in the study. We included patients who met the above
criteria and who has at least three plasma sodium mea-
surements during their hospitalization. We excluded pa-
tients with a known previous history of chronic renal
failure or dialysis dependent renal failure.
All patients included in the study were resuscitated
under a standard burn resuscitation protocol. This in-
cluded calculation of fluid requirements for acute burn
resuscitation using the Parkland formula. All patients
were resuscitated using lactated Ringer’s solution or nor-
mal saline. Hypertonic saline was not used for resuscita-
tion. All patients received standard glucose monitoring.
Glucose levels were maintained per protocol between 80
and 150 mg/dl using either intermittent insulin adminis-
tration or an insulin infusion. All measurements of
plasma sodium were performed in the hospital central
laboratory. Reference range for normal sodium measure-
ments was 135 to 145 meq/l. For the plasma sodium mea-
surements, we determined the mean sodium for each
patient and the mean standard deviation (SD) of sodium
for each patient. Hypernatremic measurements were
defined as any sodium measurement greater than
145 meq/l. Hyponatremia was defined as any sodium
measurement less than 135 meq/l.
Data was analyzed using R statistical package (www.r-
project.org). For all analyses, significance levels were set
at a p < 0.05. Normality of the data was tested using the
Shapiro-Wilk test of normality. Comparisons of means
between two groups of normally distributed data were
performed using the student’s t test. For non-normally
distributed data, the Mann-Whitney U test was used to
compare differences between groups. The chi-square test
was used to assess association between discrete categor-
ical variables. Variability of sodium measurements was
assessed by the coefficient of variation (CV) which is the
SD divided by the mean multiplied by 100. Multivariate
logistic regression analysis was performed to determine
associations between categorical outcome variables and
independent continuous and categorical predictor vari-
ables. For our multivariate model, the outcome variable
was mortality. The input variables were determined in a
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stepwise subtraction method. Final model determination
was made with the following criteria: input variables that
were independently and significantly associated with the
outcome variable and the Akaike Information Criterion
(AIC). There were issues of collinearity in the regression
model and the best-fit model did not include hyperna-
tremia or hyponatremia. The occurrence of hypernatre-
mia was rare even in non-survivors, and CV can take
into account the potential association of sodium dysna-
tremia in a larger population of burn patients. We used
only significant variables into the model. We then re-
moved variables from the model that did not reach stat-
istical significance with respect to predicting mortality.
For variables that had “zero” values, we included them
in the models using the same criteria for p value. We
used the AIC to determine if the variables should con-
tinue to remain in the model. We confirmed that the
remaining variables in the model were the best fit
through determining the AIC. The AIC for the model
presented was 40, which was lower than that for the
model with the starting set of variables. This left us with
the following input variables for the model: age, %TBSA,
ventilator days, ICU days, and mean SD of plasma so-
dium. None of these variables contained any zero or null
values.
Results
Patient demographics
Out of the 212 patients entered into the study, 29 pa-
tients died (14%). The mean age and burn severity were
approximately 45 years and 32%TBSA, respectively. Me-
dian ventilator days and length of ICU stay were 2 and
22 days. There were four patients admitted with pre-
injury chronic renal failure, 38 patients who developed
acute renal failure during hospitalization, and two who
required dialysis during hospitalization. Plasma sodium
was measured 10,310 times for a median of 22 plasma
sodium measurements per patient (Table 1). Overall,
41% of plasma sodium measurements were below
135 meq/l and only 1.6% of measurements were above
145 meq/l.
Non-survivors suffer from more hypernatremia and
higher sodium variability
As expected, non-survivors were older (59 vs. 42 years,
p < 0.0003) and suffered on average a larger burn injury
(50% vs. 29%TBSA, p < 0.0001). Non-survivors also had
a significantly longer median length of mechanical venti-
lation (17 vs. 1 day, p < 0.00001). There was no differ-
ence in median length of ICU stay (18 vs. 20 days,
p = 0.23). Non-survivors suffered from significantly
higher rates of acute renal failure than survivors (72% vs.
9.2%, p < 0.0001). Non-survivors had a significantly
higher median number of plasma sodium measurements
(35 vs. 20, p = 0.03) and also had a significantly higher
mean sodium concentration (138 meq/l vs. 135 meq/l,
p < 0.01) compared to survivors. The median number of
hyponatremic sodium measurements was not different
between non-survivors and survivors (13 vs. 9, p = 0.79).
In contrast, the median number of hypernatremic
plasma sodium measurements was significantly higher in
non-survivors (2 vs. 0, p < 0.01). Additionally, the me-
dian percentage of hypernatremic plasma sodium mea-
surements was also significantly higher in non-survivors
(6% vs. 0%, p < 0.01). Hyponatremia was more frequent
in survivors (40% vs. 20%, p < 0.01). The SD of the mea-
sured sodium values was calculated for each patient as
an indication of sodium variability. Comparisons of the
CV of the measured sodium values showed that non-
survivors had significantly higher sodium variability
(CV = 2.85 ± 1.1) compared to survivors (CV = 2.0 ± 0.7,
p < 0.01) (Table 2).
Large ranges of plasma sodium measurements in the first
2 weeks after burn injury are associated with mortality
We examined the range of sodium measurements fol-
lowing admission to determine if there was a time-
dependent association between changes in plasma so-
dium and death. We analyzed sodium measurements
over 5-day intervals from admission to death or dis-
charge and calculated a range. The mean range of so-
dium in the first 5 days was 7.8 ± 3 meq/l for survivors
and 10 ± 5 meq/l for non-survivors (p < 0.009). From
days 6 to 10, the mean range for survivors was
4 ± 2.5 meq/l and for non-survivors was 6 ± 2.7 meq/l
Table 1 Patient demographics of overall study
Patient demographic
Males 164
Females 48
Lived 183
Died 29
Burn area (%TBSA) 32 ± 19
Age (years) 44.6 ± 18
ICU stay (median days) 22 (15–39)
Mechanical ventilation (median days) 2 (0–15)
Acute renal failure 38
Chronic renal failure 4
Dialysis 2
Sodium measurements (median) 22 (12–51)
Mean sodium concentration (meq/l) 135.5 ± 2.4
Mean sodium standard deviation 2.9 ± 1.1
All mean values are mean ± standard deviation, all median values are median
(interquartile range)
TBSA total body surface area, ICU intensive care unit, meq/l milliequivalents
per liter
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(p < 0.000001). After day 10, there were no significant
differences in ranges between survivors and non-
survivors. We then performed a multivariate regression
model that adjusted for age and TBSA and found the in-
creased sodium range 6 to 10 days after admission was
associated with an increased risk of death (OR 1.35
(1.06–1.7).
Plasma sodium variability is independently associated
with mortality
A multivariate model was constructed to determine in-
dependent predictors for mortality in this patient sam-
ple. Increased age (OR 1.17, p = 0.002), larger burn size
(OR 1.2, p = 0.0006), and increased length of mechanical
ventilation (OR 1.3, p = 0.009) are all independent sig-
nificant risk factors for death. Increased length of ICU
time (OR 0.72, p = 0.0006) increases the likelihood of
survival. This probably reflects the fact that survivors
had an overall longer hospital course than non-
survivors. For the effect of plasma sodium on mortality,
increased CV, reflecting plasma sodium variability, is an
independent risk factor for death (OR 5.8, p = 0.01)
(Table 3).
Discussion
Dysnatremia is a significant risk factor for mortality in
critically ill patients [19]. A recent study investigating
the effects of dysnatremia on mortality in patients with
community-acquired pneumonia found that both hypo-
natremia and hypernatremia were significantly associ-
ated with death. Furthermore, the investigators found
that extreme alterations of sodium concentrations have a
higher hazard ratio for mortality [20]. The effect of
hypernatremia on mortality may be more impactful than
hyponatremia. Several retrospective studies have shown
a mortality rate range of 30% to 48% for patients with
severe hypernatremia (> 150 meq/l) [21]. In critically ill
burn patients, hypernatremia is a common condition
and can occur in up to 11% of severely burned patients.
The most common etiology underlying the development
of hypernatremia is loss of total body water through in-
sensible losses and sepsis [22, 23]. A recently published
study by Stewart et al. shows that similar to critically ill
medical patient, hypernatremia is a risk factor for mor-
tality in burn patients. This study investigated an effect
of dysnatremias on mortality in all burn patients (mean
TBSA of 9%) [24]. In contrast, our investigation exam-
ined the association of dysnatremia on mortality in pa-
tients with larger burn injuries (mean TBSA of 32%).
The Stewart study showed that hyponatremia occurred
in 6.8% of patients and hypernatremia occurred in 9.9%
Table 2 Survivors vs. non-survivors
Patient demographic Survivors Non-survivors p value
Males 142 22
Females 41 7 1
Burn area (%TBSA) 29 ± 16 50 ± 25 < 0.01
Age 42 ± 16 59 ± 19 < 0.01
ICU stay (median days) 20 (13–38.5) 18 (8–36) 0.23
Mechanical ventilation (median days) 1 (0–10) 17 (7–36) < 0.01
Acute renal failure 17 (9.2%) 21 (72%) < 0.01
Sodium measurements (median) 20 (12–44.5) 35 (23–89) 0.04
Hyponatremic measurements (median) 9 (4–17.5) 13 (2 to 21) 0.79
Hypernatremic measurements (median) 0 (0) 2 (0–7) < 0.01
Frequency of hyponatremia (median) 40% (24–62%) 20% (11–40%) < 0.01
Frequency of hypernatremia (median) 0% (0%) 6% (0–8.6%) < 0.01
Mean sodium concentration (meq/l) 135 ± 1.9 138 ± 3.4 < 0.01
Mean sodium standard deviation 2.7 ± 1 4 ± 1.5 < 0.01
Coefficient of variation 2.0 ± 0.7 2.85 ± 1.1 < 0.01
Patient demographic. All mean values are mean ± standard deviation, all median values are median (interquartile range)
TBSA total body surface area, ICU intensive care unit, meq/l milliequivalents per liter
Table 3 Multivariate logistic regression model for risk factors of
death
Variable Odds ratio 95% CI p value
TBSA 1.2 1.1–1.3 0.0006
Age 1.17 1.1–1.3 0.002
Mechanical ventilation days 1.3 1.1–1.5 0.0009
Length of ICU stay 0.72 0.6–0.9 0.0006
Coefficient of variation 5.8 1.5–22 0.01
Multivariate logistic regression model assessing for independent risk factors
that are associated with death
TBSA total body surface area, ICU intensive care unit, CI confidence interval
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of patients. Our study showed a higher rate of dysnatre-
mia with over 42% of the sodium measurements either
above or below the normal range. Our study also
showed that hypernatremia is more common in patients
who died and that the mean plasma sodium concentra-
tion was higher in non-survivors. In our study sample,
there were very few occurrences of hypernatremia in
both survivors and non-survivors. However, this was sta-
tistically different between the survivors and non-
survivors. Since the incidence of hypernatremia was very
low even in non-survivors, hypernatremia as clinical
marker may not be valuable because the majority of so-
dium values were either normal or low in non-survivors.
Higher sodium variability as compared to hypernatremia
may be better associated with mortality from a clinical
standpoint because sodium variability may more often
reflect the degree of perturbation of sodium physiology
than the infrequent occurrence of hypernatremia. Add-
itionally, sodium variability may likely be present with or
without hypernatremia, as such may be a more timely
reflection in sodium metabolism and physiologic condi-
tion. Our multivariate analysis indicates that plasma
sodium variability and not hypernatremia is an inde-
pendent risk factor for mortality. This is probably due to
the higher rate of dysnatremia in our study population
and reflects the severe physiologic alterations that can
occur following a severe burn injury. Additionally, early
sodium variability may be more likely to be associated
with death than late variability.
There are several limitations to this study. First, this
was a retrospective cohort designed study. The effect
of other variables specifically age and burn injury
have a significant effect on mortality at admission,
and it is likely the case that plasma sodium reflects
changes in metabolism and physiology that develop
over time and are a result of increased age or larger
burn injury. Second, we were not able to assess the
timing of acute renal failure with sodium variability.
Acute renal failure was a diagnosis made by the treat-
ing physicians, and thus, variability likely exists in the
timing and criteria used to make the diagnosis. A
prospective study that analyzes the temporal relation-
ship between sodium physiology and acute renal fail-
ure would provide the best analysis to determine the
relationship between sodium and renal function.
Third, we were not able to analyze the influence of
intravenous fluid administration on sodium variability.
All patients were resuscitated based on the Parkland
formula (4 ml per kg per %TBSA); however, adjust-
ments of fluid rates for resuscitation may have been
made due to a number of factors. Delays in treat-
ment, severity or cause of burn injury, concomitant
injuries, inhalation injury, chemical, or illicit sub-
stance ingestions can all alter the acute resuscitation
of burn patients. Additionally, daily weights could not
be included in our analysis because they were variably
collected in the patient charts. All maintenance fluid
rates were based on the patients’ weight and evapora-
tive loss due to the burn injury; however, the treating
clinical team adjusted these rates based on their clin-
ical decisions and thus cannot be normalized in a
way that is comparable. A prospective study would
add greatly to the influence of intravenous fluid
amounts and sodium variability. Fourth, our current
study does not directly aid clinicians about dysnatre-
mia or sodium variability. Sodium variability would be
difficult for a clinician to determine in a patient given
the need to analyze and calculate the variability over
a given time period (e.g., 7 days). It is likely that two
things are needed in order for sodium variability to
become a clinically useful marker. One, a prospective
study needs to be completed that established the rela-
tionship between sodium variability over different
time periods with current and future physiologic con-
ditions. Two, once established, sodium variability
limits can then be presented with laboratory analysis
or through clinical calculators that will provide clini-
cians with established parameters to aid in their as-
sessments of a patient’s clinical condition. Despite
these limitations, our analysis indicates that hyperna-
tremia is more prevalent in burn patients who die
and that increased plasma sodium variability may be
a risk factor for death.
Conclusions
Dysnatremias may be a marker for poor outcomes and in-
creased mortality for severely burned patients. The etiology
for dysnatremias is multifactorial for burn patients, and in-
creased variability of plasma sodium concentrations may be
associated with an increased risk of death.
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